Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-03, Stock:PFE, The news for the past five days is as follows:
2020-10-27: NEWS1: ‘Someone, somewhere in the U.S. is getting overwhelmed’ with the rising numbers of covid cases: UC Davis Health.NEWS2: Moderna Vaccine Gets U.K. "Rolling Review"; Novavax Expands Trials.NEWS3: Pfizer Earnings Beat But Sales Miss; Crucial Covid-19 Vaccine Trials Advance.NEWS4: Stocks End Mixed as Virus Cases Surge; Tech Lifted by AMD-Xilinx.NEWS5: Analyst Report: Pfizer Inc..NEWS6: Coronavirus Latest: Tuesday, October 27.NEWS7: Most efficacious, safest COIVD-19 vaccine ‘is going to be the winner’: Strategist.NEWS8: Eli Lilly slumps after earnings miss, paused COVID-19 antibody trial.NEWS9: Dow Falls as Virus Cases Surge; Tech Gets Lift From AMD's Buy of Xilinx.NEWS10: How Pfizer Missed an Opportunity With Its Q3 Results.NEWS11: Pfizer’s Covid-19 vaccine doesn’t add a ‘tremendous amount’ to the company’s valuation: Analyst.NEWS12: CAT earnings show slow in demand, 3M sees strong earnings on safety equipment sales.NEWS13: The Zacks Analyst Blog Highlights: Pfizer, Merck & Co., Bristol-Myers Squibb and Amgen.NEWS14: Pfizer (PFE) Q3 Earnings Top, Sales Miss, View Narrowed.NEWS15: Caterpillar, Pfizer, 3M Earnings Come In Better Than Expected, With Microsoft Straight Ahead.NEWS16: Pfizer CEO: may be a week between conclusive vaccine data, public notification.NEWS17: Dow Falls After Sharp Selloff, Tech Gets Lift From AMD Buy of Xilinx.NEWS18: Pfizer (PFE) Q3 Earnings Beat Estimates.NEWS19: Pfizer Stock Is Lower Because the Covid-19 Vaccine Looms Over Earnings.NEWS20: Stuck Americans Spend on DIY Projects and Crocs: Earnings Wrap.NEWS21: Pfizer Earnings Miss But Sales Beat; Crucial Covid-19 Vaccine Trials Advance.NEWS22: Pfizer Tops Q3 Earnings Forecast, Narrows 2020 Profit Target; Sees November Vaccine Application to FDA.NEWS23: The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings.NEWS24: Pfizer says no COVID-19 vaccine data yet, could be week or more before it reports.NEWS25: Pfizer Earnings Mixed; Drug Giant Steady.NEWS26: Pfizer cites $500 million impact in the third quarter as a result of the COVID-19 pandemic.NEWS27: Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global Pact.NEWS28: Recap: Pfizer Q3 Earnings.NEWS29: FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis.NEWS30: Pfizer says no COVID-19 vaccine data yet, could be week or more before it reports.NEWS31: 3 Dirt-Cheap Dividend Stocks to Buy Today.NEWS32: PFIZER REPORTS THIRD-QUARTER 2020 RESULTS.
2020-10-28: NEWS1: Britain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's -Times.NEWS2: Amgen’s Earnings and Sales Climb, Driven by Its Biosimilars.NEWS3: Why Pfizer Stock Dropped Today.NEWS4: ‘We could see daily averages well over 1,000 deaths per day’ going into winter: doctor.NEWS5: Coronavirus Latest: Wednesday, October 28.NEWS6: Coronavirus update: Case surges spark fear in markets globally; experts wary about a vaccine by the end of the year.NEWS7: Company News for Oct 28, 2020.NEWS8: EU must step up response to COVID-19, Commission warns as infections spike.NEWS9: Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks.NEWS10: Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?.NEWS11: AstraZeneca and J&J Resume Late-Stage Trials: How It Shakes Up the Coronavirus Vaccine Race.NEWS12: Exelixis' (EXEL) Applications for Cabometyx-Opdivo Combo Accepted (Revised).NEWS13: PRESS DIGEST- New York Times business news - Oct 28.NEWS14: Pfizer (PFE) Q3 2020 Earnings Call Transcript.
2020-10-29: NEWS1: Moderna Third-Quarter Earnings Show Soaring Revenue, R&D Costs.NEWS2: Coronavirus Latest: Thursday, October 29.NEWS3: Top Research Reports for UnitedHealth, Adobe & Pfizer.NEWS4: Fauci says first U.S. COVID-19 vaccines could ship late December or early January.NEWS5: NYC Positive Rate Spikes; Midwest Surge at Record: Virus Update.NEWS6: Why BioNTech Stock Is Jumping Today.NEWS7: Moderna Stock Jumps as Biotech Rakes in Revenue for Covid Vaccine.NEWS8: Amgen (AMGN) Losing Altitude Despite Strong Quarter.NEWS9: UK Government Expects Verdict On Pfizer's Vaccine Before Christmas: Report.NEWS10: Got $1,000? These 2 Top Stocks Are Great Buys Right Now.NEWS11: Here's the Clear Leader in Developing a Coronavirus Vaccine for Kids.NEWS12: Here's the Clear Leader in Developing a Coronavirus Vaccine for Kids.NEWS13: Pfizer or Merck: Which Pharma Stock Has More Upside Potential?.NEWS14: Britain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's - Times.NEWS15: PRESS DIGEST-British Business - Oct.29.
2020-10-30: NEWS1: Overconfident Predictions for Stocks, the Election, and a Covid-19 Vaccine.NEWS2: Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit.NEWS3: U.K. regulator is accelerating reviews of COVID-19 vaccines from Pfizer and AstraZeneca, according to a report.NEWS4: Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn.NEWS5: How Novavax Has a 2-Pronged Approach to Vaccine Sales.NEWS6: Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study.NEWS7: Novavax lays out specific minority targets for U.S. COVID-19 vaccine trial.NEWS8: U.S. approves combination of Pfizer's Upjohn and Mylan.NEWS9: The Zacks Analyst Blog Highlights: UnitedHealth Group, Adobe, Pfizer, Intel and T-Mobile US.NEWS10: UK starts accelerated reviews for COVID-19 vaccines from AstraZeneca and Pfizer - Bloomberg.NEWS11: What's the Outlook for BioNTech Stock?.NEWS12: What's the Outlook for BioNTech Stock?.
2020-11-02: NEWS1: Pfizer To Bypass US Government System For COVID Vaccine Distribution.NEWS2: A Pfizer Analyst's 3 Possible Coronavirus Vaccine Readout Scenarios.NEWS3: The Zacks Analyst Blog Highlights: Eli Lilly, Merck, Pfizer, Novartis, AstraZeneca and J&J.NEWS4: CureVac’s COVID-19 vaccine shows immune response in Phase 1 trial.NEWS5: Mylan (MYL) to Report Q3 Earnings: Is a Beat in the Cards?.NEWS6: 2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020.NEWS7: Early Covid-19 Vaccine Hopes Have a Math Problem.NEWS8: Here’s What a Covid-19 Vaccine Could Be Worth to Pfizer Stock.NEWS9: It Might Not Be A Great Idea To Buy Pfizer Inc. (NYSE:PFE) For Its Next Dividend.NEWS10: A Covid-19 Vaccine Faces a Major Hurdle.

Answer: Decrease